ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

ClinicalTrials.gov ID: NCT00005947

Public ClinicalTrials.gov record NCT00005947. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 8:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Placebo Controlled Trial of Immunotherapy With Autologous Antigen-Loaded Dendritic Cells (Provenge) for Asymptomatic Metastatic Hormome-Refractory Prostate Cancer

Study identification

NCT ID
NCT00005947
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dendreon
Industry
Enrollment
127 participants

Conditions and interventions

Interventions

  • Placebo Biological
  • sipuleucel-T Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 1999
Primary completion
Aug 31, 2004
Completion
Aug 31, 2004
Last update posted
Oct 31, 2010

1999 – 2004

United States locations

U.S. sites
34
U.S. states
11
U.S. cities
29
Facility City State ZIP Site status
Cancer Center and Beckman Research Institute, City of Hope Duarte California 91010-3000
Loma Linda University Medical Center Loma Linda California 92354
Cancer and Blood Institute of the Desert Rancho Mirage California 92270
Eisenhower Medical Center Rancho Mirage California 92270
Sidney Kimmel Cancer Center San Diego California 92121
UCSF Cancer Center and Cancer Research Institute San Francisco California 94143-0128
Office of Glenn Tisman Whittier California 90601
Office of Barry S. Berman Orlando Florida 32806
Mayo Clinic Cancer Center Rochester Minnesota 55905
Hackensack University Medical Center Hackensack New Jersey 07601
St. Barnabas Medical Center Livingston New Jersey 07039
Morristown Memorial Hospital Morristown New Jersey 07962-1956
Albany Regional Cancer Center Albany New York 12208
Center for Medical Oncology Garden City New York 11530
St. Vincents Comprehensive Cancer Center New York New York 10011
NYU School of Medicine's Kaplan Comprehensive Cancer Center New York New York 10016
St. Luke's-Roosevelt Hospital New York New York 10019
New York Presbyterian Hospital - Cornell Campus New York New York 10021
University of Rochester Cancer Center Rochester New York 14642
Albert Einstein Comprehensive Cancer Center The Bronx New York 10461
New York Medical College Valhalla New York 10595
AKSM Clinical Research Corporation Columbus Ohio 43214
Earle A. Chiles Research Institute at Providence Portland Medical Center Portland Oregon 97213-2967
Abington Hematology Oncology Associates, Incorporated Abington Pennsylvania 19001
Bryn Mawr Urology Bryn Mawr Pennsylvania 19010
Office of Guy Bernstein, M.D. Bryn Mawr Pennsylvania 19010
Saint Mary Regional Cancer Center Langhorne Pennsylvania 19047
North Penn Hospital Lansdale Pennsylvania 19446-1200
Hematology/Oncology Associates of NE Pennsylvania, P.C. Scranton Pennsylvania 18510
American Oncology Resources Dallas Texas 75246
Devine Tidewater Urology Norfolk Virginia 23507
Seattle Cancer Care Alliance Seattle Washington 98109
Cancer Care Northwest Spokane Washington 99202
Hematology Oncology Northwest, P.C. Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00005947, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2010 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005947 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →